ArticleJournal of the National Cancer Institute2013
Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.
Dennis C Sgroi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
112 papers cite itlatest 60 shown
this paperpooled ittrialcites it